Related Experiment Videos
Unsaturated B12-binding proteins in amniotic fluid of cystic fibrosis-affected foetus
M Vidailhet1, J L Gueant, L Hambaba
1Pediatric Unit, Laboratory of Pediatric Biochemistry, Faculty of Medicine, Nancy, France.
Insights
Researchers investigated amniotic fluid B12-binding proteins for cystic fibrosis diagnosis. Abnormalities were not found, indicating this method is not useful for antenatal screening of cystic fibrosis.
Area of Science:
- Biochemistry
- Medical Genetics
- Prenatal Diagnostics
Background:
- Cystic Fibrosis (CF) is a genetic disorder.
- Amniotic fluid contains various proteins, including B12-binding proteins.
- Potential alterations in these proteins could serve as diagnostic markers.
Purpose of the Study:
- To investigate quantitative and qualitative differences in amniotic fluid B12-binding proteins between normal and cystic fibrosis pregnancies.
- To determine if B12-binding protein analysis can aid in the antenatal diagnosis of cystic fibrosis.
Main Methods:
- Analysis of 7 cystic fibrosis and 59 normal amniotic fluid samples.
- Utilized radioimmunogel filtration, radioisotope techniques, and isoelectric focusing chromatography.
- Assessed unsaturated B12-binding capacity, molecular weights, and isoelectric points of specific binding proteins.
Main Results:
- Normal amniotic fluid showed increased unsaturated B12-binding capacity with gestational age.
- No statistically significant differences were observed in B12-binding proteins (haptocorrin, transcobalamin 2, intrinsic factor) between CF and normal amniotic fluid.
- Key parameters like molecular weight and isoelectric point were consistent across groups.
Conclusions:
- Amniotic fluid B12-binding protein profiles do not differ significantly in cystic fibrosis.
- Analysis of these proteins is not a viable method for antenatal diagnosis of cystic fibrosis.
- Further research may explore other biomarkers for early CF detection.
Abstract:
The authors hypothesized the possibility of quantitative or qualitative abnormalities of amniotic fluid B12-binding proteins in cystic fibrosis. Seven cystic fibrosis and 59 normal amniotic fluids sampled between 17.5 and 18.5 gestational weeks were studied by radioimmunogel filtration, radioisotope technique, and isoelectric focusing chromatography. In normal amniotic fluid there was an increase of unsaturated B12-binding capacity from 16 to 41 weeks of gestation. There was no statistically significant difference in unsaturated B12-binding capacity, molecular weights and isoelectric points of haptocorrin, transcobalamin 2, and intrinsic factor between cystic fibrosis and normal amniotic fluid. Cobalamin-binding proteins study cannot help in the antenatal diagnosis of cystic fibrosis.